This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2012-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2018
Title: Agnieszka Patkaniowska: Innovator in RNA-Interference Technology
Introduction
Agnieszka Patkaniowska is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of molecular biology, particularly in the area of RNA-interference technology. With a total of 3 patents to her name, her work has the potential to impact various applications in genetic research and therapeutics.
Latest Patents
One of her latest patents focuses on RNA-interference by single-stranded RNA molecules. This invention relates to the sequence and structural features of single-stranded (ss)RNA molecules that are required to mediate target-specific nucleic acid modifications by RNA-interference (RNAi). These modifications can include target mRNA degradation and/or DNA methylation, showcasing the innovative nature of her research.
Career Highlights
Agnieszka is affiliated with the Max Planck Society for the Advancement of Science, where she continues to push the boundaries of scientific research. Her work has garnered attention for its potential applications in gene therapy and other biotechnological advancements.
Collaborations
Throughout her career, Agnieszka has collaborated with notable scientists such as Thomas Tuschl and Javier Martinez. These partnerships have further enriched her research and contributed to the advancement of RNA-interference technologies.
Conclusion
Agnieszka Patkaniowska stands out as an influential inventor in the field of RNA-interference technology. Her innovative patents and collaborations highlight her commitment to advancing scientific knowledge and applications in molecular biology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
